-
ERT Launches 'Centralized Cardiac Safety 2.0': A Revolutionary New Approach to ECG Management in Clinical Trials
PHILADELPHIA, March 10 /PRNewswire-FirstCall/ -- ERT (Nasdaq: ERES), a leading provider of centralized services to the biopharmaceutical, medical device and related industries, today announced the launch of Centralized Cardiac Safety 2.0, a portfolio of new solutions that enable a significant new ap
-
Toxikon Corporation Hosts Extractables and Leachables Spring Seminar
BEDFORD, Mass., March 10 /PRNewswire/ --Toxikon Corporation, a preclinical contract testing lab, invites quality assurance, research and development and regulatory professionals to Bedford, Massachusetts April 20 for an international symposium on extractables and leachables testing.
The increased u
-
BR Ventures Invests in Semprae Laboratories
Student-run venture fund joins Quaker BioVentures in Series A round
ITHACA, N.Y., March 10 /PRNewswire-USNewswire/ -- BR Ventures (BRV), an MBA student-run venture fund of the Johnson School at Cornell University, today announced that it has invested in Semprae Laboratories, joining Quaker Bioscienc
-
Codexis Names Vonnie Estes to New Technology Strategic Planning VP Role
REDWOOD CITY, Calif., March 10 /PRNewswire/ -- Codexis, Inc. today announced that Vonnie Estes has joined the company as Vice President, Strategic Planning, Technology. In this new position, Ms. Estes will be responsible for moving Codexis' technical developments to commercial applications.
-
Bacterin International Introduces OsteoSelect(R) DBM Putty
BELGRADE, Mont., March 10 /PRNewswire/ -- Bacterin International, Inc. (Bacterin), a biologic company focused on the development of innovative, specialty allografts, announces the introduction of OsteoSelect® DBM Putty for orthopedic bone grafting applications. OsteoSelect® is a mold
-
Cumberland Pharmaceuticals Reports 24% Increase in Net Revenue With Full Year 2009 Financial Results
NASHVILLE, Tenn., March 10 /PRNewswire-FirstCall/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on the hospital acute care and gastroenterology markets, today announced full year 2009 financial results.
"The approval and launch of Caldolor and our init
-
WaferGen Announces Eight New Early-Access Customers; Ships First International SmartChip System Following CE Certification
FREMONT, Calif., March 10 /PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art genetic analysis systems, today announced eight new early-access customers that include major universities and service providers in the U.S. and Japan. Th
-
Keryx Biopharmaceuticals to Present at the 22nd Annual ROTH OC Growth Stock Conference
NEW YORK, March 10 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that Ron Bentsur, the Company's Chief Executive Officer, will be presenting at the 22nd Annual ROTH OC Growth Stock Conference, being held in Laguna Niguel, CA. Mr. Bentsur's presentation will
-
Boston Scientific Announces Schedule for ACC 2010
NATICK, Mass., March 10 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and news announcements at the 59th Annual Scientific Session of the American College of Cardiology/i2 Summit, March 13-16 in Atlanta.
"We look forwa
-
Catalyst Pharmaceutical Partners to Present at the BioNetwork East 2010 Conference
CORAL GABLES, Fla., March 10 /PRNewswire-FirstCall/ -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX) announced that Patrick J. McEnany, Catalyst's Chief Executive Officer, will be making a presentation at the BioNetwork East 2010 Conference to be held March 15th through March 17th at the Ede
-
China-Biotics, Inc. Announces the Results of the 2009 Annual Stockholders Meeting
SHANGHAI, March 10 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc.
("China-Biotics", the "Company") (Nasdaq: CHBT), a leading developer,
manufacturer and distributor of probiotics products in China, today announced
the results of its 2009 Annual Meeting of Stockholders ("AGM") held on Friday,
-
Watson Announces Actos(R) Patent Challenge Settlement
MORRISTOWN, N.J., March 10 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), today announced that it has reached a settlement agreement with Takeda Pharmaceutical Company Limited and Takeda Pharmaceuticals North America resolving outstanding patent litigation related to Watson's ge
-
An Acute Migraine Therapy That is Not Contraindicated in Patients With a History of Vascular Disease Would Earn a 45 Percent Patient Share in the United States, According to Surveyed Neurologists
WALTHAM, Mass., March 10 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that an acute migraine therapy that is not contraindicated in patients with a history, symptoms or signs of vascular disease and also of
-
China Sky One Medical Announces Conference Call to Discuss Fourth Quarter and Full Year 2009 Results
HARBIN, China, March 10 /PRNewswire-Asia-FirstCall/ -- China Sky One
Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a
leading fully integrated pharmaceutical company producing over-the-counter
drugs in the People's Republic of China ("PRC"), today announced that it will
-
American Oriental Bioengineering to Report Fourth Quarter and Full Year 2009 Financial Results on March 15, 2010
NEW YORK, March 10 /PRNewswire-Asia-FirstCall/ -- American Oriental
Bioengineering, Inc. (NYSE: AOB), ("the Company" or "AOBO"), a pharmaceutical
company dedicated to improving health through the development, manufacture and
commercialization of a broad range of prescription and over the counter
-
China Medicine Corporation Applies to List on NASDAQ Global Market
GUANGZHOU, China, March 10 /PRNewswire-Asia/ -- China Medicine Corporation
(OTC Bulletin Board: CHME) ("China Medicine" or "the Company"), primarily a
leading distributor and a developer of Western pharmaceuticals, traditional
Chinese medicines ("TCM"), and other nutriceuticals, announced today
-
BASF Podcast: The Chemical Reporter - What are Fungicides?
LUDWIGSHAFEN, Germany, March 10, 2010 /PRNewswire/ -- Just like animals
and human beings, plants can get sick. In many cases, the cause is a fungus.
Not a mushroom like you see poking up out of the ground in the woods, but a
network of branching, filamentary cells that botanists call 'hyphae'. I
-
Cempra Announces the Completion of Phase 1 Studies for CEM-101, a Next-Generation Macrolide
CHAPEL HILL, N.C., March 10 /PRNewswire/ -- Cempra Pharmaceuticals today announced the successful completion of Phase 1 clinical trials of its oral formulation of CEM-101, which showed good tolerability in those studies. The company also announced plans to submit an IND to the FDA to begin a Phase 1
-
Cellzome Announces Second Major Strategic Drug Discovery Alliance with GlaxoSmithKline in Inflammatory Disease
Collaboration Exploits Cellzome's World-Leading Proteomics Technology in
Epigenetics
CAMBRIDGE, England and HEIDELBERG, Germany, March 10, 2010 /PRNewswire/
-- Cellzome today announced that it has formed a second strategic alliance
with GlaxoSmithKline (GSK). This new collaboration gives G
-
3SBio Announces Changes to its Board of Directors
SHENYANG, China, March 10 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc.
(Nasdaq: SSRX), a leading biotechnology company focused on researching,
developing, manufacturing and marketing biopharmaceutical products primarily
in China, today announced changes to its board of directors (the "Board"). Ms.
|